## BRO: Brown & Brown, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -1.1% below STRENGTH zone (4.0-10.0%); PEG 4.41 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($76.67)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 4)

**1. This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday**
- Source: Benzinga | 20251223T132946 | Somewhat-Bearish | Relevance: 100%
- This article details four significant analyst downgrades that occurred on Tuesday. Analysts from Evercore ISI Group, BMO Capital, Itau BBA, and TD Cowen have revised their outlooks on Coty Inc, Brown & Brown Inc, Southern Copper Corp, and Janus Henderson Group PLC, respectively, leading to lower price targets and less bullish ratings. These changes reflect updated financial assessments from top Wall Street analysts.

**2. Brown & Brown (NYSE:BRO) Delivers Impressive Q3 CY2025**
- Source: FinancialContent | 20251223T110700 | Bullish | Relevance: 100%
- Brown & Brown (NYSE:BRO) reported impressive Q3 CY2025 results, exceeding revenue and adjusted EPS expectations. The insurance brokerage firm saw sales increase by 35.4% year-on-year to $1.61 billion, driven primarily by M&A and profit-sharing contingent commissions, with adjusted EPS of $1.05 per share. Despite a dip in operating and free cash flow margins, the company's long-term revenue and EPS growth remain strong.

**3. Brown & Brown (BRO): Evaluating Valuation After a 21% Share Price Decline Despite Ongoing Profit Growth**
- Source: Simply Wall Street | 20251223T100748 | Somewhat-Bullish | Relevance: 100%
- Brown & Brown (BRO) has seen its share price drop about 21% over the past year despite consistent revenue and net income growth of approximately 15% annually. Analysts suggest a fair value of $92.86 for the stock, indicating it might be undervalued, yet other valuation metrics hint at potential risk. The article explores whether the market is accurately pricing in future growth or if the stock is indeed slipping into an undervalued territory.

**4. Brown & Brown sues Howden and former employees as broker 'raid' swells to 300**
- Source: theinsurer.com | 20251223T215844 | Bearish | Relevance: 100%
- Brown & Brown has filed a lawsuit against Howden and 29 individuals after Howden U.S. reportedly hired nearly 300 Brown & Brown employees. This hiring spree is part of Howden's expansion to bolster its employee benefits practice and enter the Northeast and Midwest regions.

**5. Brown & Brown cut to market perform as BMO sees softer organic growth**
- Source: MSN | 20251223T170141 | Bearish | Relevance: 100%
- BMO Capital has downgraded Brown & Brown (BRO) to market perform, noting that the company's recent organic growth is likely to trend softer than in 2022. While acknowledging the company's strong execution and attractive financial profile, BMO highlighted potential headwinds including a slowing economy and moderation in commercial insurance pricing.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | BMO Capital | $88 | $90 | -2% |
| 2025-12-18 | JP Morgan | $91 | $0 | 0% |
| 2025-12-16 | Mizuho | $89 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | BMO Capital | down | Market Perform |
| 2025-12-18 | JP Morgan | init | Neutral |
| 2025-12-16 | Mizuho | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.00M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.9% (+4.8%)
- Blackrock Inc.: 6.1% (+2.2%)
- Capital World Invest: 5.1% (+81.1%)
- Principal Financial : 4.5% (+13.4%)
- State Street Corpora: 3.8% (+5.3%)

### Key Risks

1. Valuation stretched: PEG 4.4x requires aggressive growth execution.
2. Long-term trend broken: trading 19.8% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.41 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Revenue growth strong at 23% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.3B |
| Beta | 0.81 |
| 52W Range | $76.17 - $125.68 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.41 |
| Forward P/E | 17.1 |
| Current P/E | 18.8 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.0% to -1.1% (-4.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.1pp (needs >4.0% for momentum thesis). Below SMA200 (0.80x), long-term trend not supportive. RSI neutral at 47. Elevated volume (1.8x 20MA), institutional activity likely. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.07% (CS: 42) | Neutral |
| RSI_14 | 47.0 | Neutral |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 0.979x | Below |
| vs SMA200 | 0.802x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $79.97
- **Stop Loss:** $76.67 (4.1% risk)
- **Target:** $83.27 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 272
- **Position Value:** $21,751.84
- **Portfolio %:** 21.75%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-26 (Est: $0.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.93 | $1.05 | +12.9% |
| 2025Q2 | $0.99 | $1.03 | +4.6% |
| 2025Q1 | $1.30 | $1.29 | -0.5% |
| 2024Q4 | $0.77 | $0.86 | +12.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*